BPG is committed to discovery and dissemination of knowledge
Number of total visits
419421
Number of visits today
149
Number of downloads
121569
MEMBERSHIP
Cited by in F6Publishing
For:
Valdez BC , Brammer JE , Li Y , Murray D , Teo EC , Liu Y , Hosing C , Nieto Y , Champlin RE , Andersson BS . Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells. Leuk Res 2016;47 :100-8. [PMID: 27294334 DOI: 10.1016/j.leukres.2016.05.019 ] [ Cited by in Crossref: 3] [ Cited by in F6Publishing: 3 ] [ Article Influence: 0.4 ] [ Reference Citation Analysis ]
Number
Citing Articles
1
Pattarawat P , Hong T , Wallace S , Hu Y , Donnell R , Wang TH , Tsai CL , Wang J , Wang HR . Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma. Br J Cancer 2020;123 :226-39. [PMID: 32390005 DOI: 10.1038/s41416-020-0877-8 ] [ Cited by in Crossref: 5] [ Cited by in F6Publishing: 5 ] [ Article Influence: 1.7 ] [ Reference Citation Analysis ]
2
Valdez BC , Li Y , Murray D , Liu Y , Nieto Y , Champlin RE , Andersson BS . Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells. Oncotarget 2018;9 :3908-21. [PMID: 29423093 DOI: 10.18632/oncotarget.23386 ] [ Cited by in Crossref: 27] [ Cited by in F6Publishing: 28 ] [ Article Influence: 4.5 ] [ Reference Citation Analysis ]
3
Smolewski P , Robak T . The discovery and development of romidepsin for the treatment of T-cell lymphoma. Expert Opin Drug Discov 2017;12 :859-73. [PMID: 28641053 DOI: 10.1080/17460441.2017.1341487 ] [ Cited by in Crossref: 22] [ Cited by in F6Publishing: 21 ] [ Article Influence: 3.7 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA California Corporate Number: 3537345
